Evidence map›Paper›PMID 23650393›Full record

Trial reportProceedings of the National Academy of Sciences of the United States of America2013

Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man.

Patricia E Burrows, Manuel L Gonzalez-Garay, John C Rasmussen, Melissa B Aldrich, Renie Guilliod, Erik A Maus, Caroline E Fife, Sunkuk Kwon, Philip E Lapinski, Philip D King and 1 more

Abstract readClinical Trial
In one paragraph

Trial report in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Mechanisms and treatments of lymphedema.Frontiers in immunology · 2026
    Review
  5. Article
  6. Central conducting lymphatic anomaly: from bench to bedside.The Journal of clinical investigation · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Lymphatic Vascular Permeability.Cold Spring Harbor perspectives in medicine · 2022
    Review
  18. Molecular Mechanisms Driving Lymphedema and Other Lymphatic Anomalies.Cold Spring Harbor perspectives in medicine · 2022
    Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Patricia E BurrowsDepartment of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Manuel L Gonzalez-Garay
John C Rasmussen
Melissa B Aldrich
Renie Guilliod
Erik A Maus
Caroline E Fife
Sunkuk Kwon
Philip E Lapinski
Philip D King
Eva M Sevick-Muraca

Funding

Imaging lymph function in humans and in a murine model of lymphedemaR01CA128919 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SEVICK, EVA M. · 2008 to 2012
$1.5M
Functional lymph angiography with NIR imagingR01HL092923 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SEVICK, EVA M. · 2008 to 2011
$1.5M
RASA1-mediated control of lymphatic vessel growth and functionR01HL096498 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KING, PHILIP D · 2009 to 2012
$1.4M
NCI NIH HHS R01 CA128919NHLBI NIH HHS R01 HL092923NHLBI NIH HHS R01 HL096498
6 · The paper itself

Abstract

Mutations in gene RASA1 have been historically associated with capillary malformation-arteriovenous malformation, but sporadic reports of lymphatic involvement have yet to be investigated in detail. To investigate the impact of RASA1 mutations in the lymphatic system, we performed investigational near-infrared fluorescence lymphatic imaging and confirmatory radiographic lymphangiography in a Parkes-Weber syndrome (PKWS) patient with suspected RASA1 mutations and correlated the lymphatic abnormalities against that imaged in an inducible Rasa1 knockout mouse. Whole-exome sequencing (WES) analysis and validation by Sanger sequencing of DNA from the patient and unaffected biological parents enabled us to identify an early-frameshift deletion in RASA1 that was shared with the father, who possessed a capillary stain but otherwise no overt disease phenotype. Abnormal lymphatic vasculature was imaged in both affected and unaffected legs of the PKWS subject that transported injected indocyanine green dye to the inguinal lymph node and drained atypically into the abdomen and into dermal lymphocele-like vesicles on the groin. Dermal lymphatic hyperplasia and dilated vessels were observed in Rasa1-deficient mice, with subsequent development of chylous ascites. WES analyses did not identify potential gene modifiers that could explain the variability of penetrance between father and son. Nonetheless, we conclude that the RASA1 mutation is responsible for the aberrant lymphatic architecture and functional abnormalities, as visualized in the PKWS subject and in the animal model. Our unique method to combine investigatory near-infrared fluorescence lymphatic imaging and WES for accurate phenoptyping and unbiased genotyping allows the study of molecular mechanisms of lymphatic involvement of hemovascular disorders.

Indexed as

Frameshift MutationAnimalsColoring AgentsDisease Models, AnimalExomeFemaleHumansHyperplasiaIndocyanine GreenLymphatic AbnormalitiesMaleMiceMice, Knockoutp120 GTPase Activating ProteinSturge-Weber SyndromeColoring AgentsIndocyanine Greenp120 GTPase Activating ProteinRASA1 protein, humanRASA1 protein, mouseCM-AVMindocyanine green imaginglymphaticsnear-infrared fluorescence imaging

Identifiers

PMID23650393
PMCPMC3666675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.